171 related articles for article (PubMed ID: 28628728)
1. Characterizing the detection threshold for optical imaging in surgical oncology.
Prince AC; Jani A; Korb M; Tipirneni KE; Kasten BB; Rosenthal EL; Warram JM
J Surg Oncol; 2017 Dec; 116(7):898-906. PubMed ID: 28628728
[TBL] [Abstract][Full Text] [Related]
2. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
3. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
[TBL] [Abstract][Full Text] [Related]
4. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.
Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM
J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070
[TBL] [Abstract][Full Text] [Related]
6. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
8. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
9. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
[TBL] [Abstract][Full Text] [Related]
10. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.
Moore LS; Rosenthal EL; de Boer E; Prince AC; Patel N; Richman JM; Morlandt AB; Carroll WR; Zinn KR; Warram JM
Mol Imaging Biol; 2017 Aug; 19(4):610-616. PubMed ID: 27830425
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety.
Bernhard W; Barreto K; El-Sayed A; Gonzalez C; Viswas RS; Toledo D; Casaco A; DeCoteau J; Fonge H; Geyer CR
BMC Cancer; 2021 Mar; 21(1):270. PubMed ID: 33711962
[TBL] [Abstract][Full Text] [Related]
12. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts.
El-Sayed A; Bernhard W; Barreto K; Gonzalez C; Hill W; Pastushok L; Fonge H; Geyer CR
Theranostics; 2018; 8(17):4856-4869. PubMed ID: 30279742
[No Abstract] [Full Text] [Related]
14. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Voskuil FJ; de Jongh SJ; Hooghiemstra WTR; Linssen MD; Steinkamp PJ; de Visscher SAHJ; Schepman KP; Elias SG; Meersma GJ; Jonker PKC; Doff JJ; Jorritsma-Smit A; Nagengast WB; van der Vegt B; Robinson DJ; van Dam GM; Witjes MJH
Theranostics; 2020; 10(9):3994-4005. PubMed ID: 32226534
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
[TBL] [Abstract][Full Text] [Related]
16. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.
Rosenthal EL; Warram JM; de Boer E; Chung TK; Korb ML; Brandwein-Gensler M; Strong TV; Schmalbach CE; Morlandt AB; Agarwal G; Hartman YE; Carroll WR; Richman JS; Clemons LK; Nabell LM; Zinn KR
Clin Cancer Res; 2015 Aug; 21(16):3658-66. PubMed ID: 25904751
[TBL] [Abstract][Full Text] [Related]
17. Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW.
Amini A; Safdari Y; Tash Shamsabadi F
Mol Imaging; 2022; 2022():9589820. PubMed ID: 35517713
[TBL] [Abstract][Full Text] [Related]
18. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.
Korb ML; Hartman YE; Kovar J; Zinn KR; Bland KI; Rosenthal EL
J Surg Res; 2014 May; 188(1):119-28. PubMed ID: 24360117
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.
Rosenthal EL; Moore LS; Tipirneni K; de Boer E; Stevens TM; Hartman YE; Carroll WR; Zinn KR; Warram JM
Clin Cancer Res; 2017 Aug; 23(16):4744-4752. PubMed ID: 28446503
[No Abstract] [Full Text] [Related]
20. The Sentinel Margin: Intraoperative
van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
